01 January 2003
Kidney donor profile in Spain: risks factors and characteristics of the organs rejected for transplantation.
B Miranda, J Canón, M T Naya, N Cuende, G Garrido, E Fernández-ZinckeAnn Transplant 2003; 8(2): 9-16 :: ID: 142808
Abstract
During recent years organ donation in Spain has increased by 100%, withimportant changes seen in the donor profile. Mean age has increased by more than 10 years, being nowadaysmore than 33% of our donors over 60 years. Ten years ago road traffic trauma was the main cause of death,while now most of our donors die due to stroke and only 21% die in a traffic accident. This changes leadto an increase in the number of kidneys discarded for transplantation every year. Among the 2517 kidneysretrieved during 2001, 567 were discarded, mainly due to different glomerular, interstitial or vascularpathologic damage. The older is the donor the higher is the percentage of kidneys discarded. It has tobe underlined that an increased number of livers from donors, whose kidneys could not be used, are beinggrafted (141 in 2001 over 281 donors from whom no kidney could be grafted and over a total number of1335 donors). Only 5% of kidneys were discarded due to technical problems. An important number of kidneyswere discarded due to malignancy suspicion or diagnosis (12.3%). Organ donation has improved but kidneytransplantation did not in parallel, due to the increasing number of kidneys discarded for transplantationin close relation with the evolution of donor's characteristics. Organ donation rate is around 33 donorsper million population while efficient organ donation rate is around 30 donors per million. Only from67% of donors both kidneys can be grafted and from 20% of donors no kidney can be used. These data willnot change our policy, at least by the moment, we will continue to evaluate every potential brain deathdonor with the aim of studying if organs can be used. It is true that in 50% of cases over 70 years noorgan can be used after retrieval and microscopic exam, but in the other 50% we can proceed.
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






